Skip to content
Inventurus Knowledge Solutions logo

Inventurus Knowledge Solutions

IKS NSE
₹1,640.80 +34.80 (+2.17%)
Market Cap
₹28,152 Cr
P/E
35.17
View as Markdown
MCP
Close 20 Nov 2026 ₹1,640.80 1Y −36.70 −2.19%
Start ₹1,677.50

Key Fundamentals

SmallcapIT - ServicesInformation Technology

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
31.50%
Debt to Equity
1.78
EPS (TTM)
₹46.65
Book Value
₹194.67
Market Cap
₹28,152 Cr
P/E (TTM)
35.17
P/B
8.43
ROE
31.40%
Dividend Yield
0.00%
EBITDA
₹1,109 Cr
52W High
₹1,970.00
52W Low
₹1,262.00
Day Range
₹1,590.90 – ₹1,648.00
Volume
95,054

Peer Comparison

Information Technology › IT - Services › IT Enabled Services

Inventurus Knowledge Solutions peer comparison
4,082.5028.1243,3106.120.49%21.50%26.70%11,6261,542
727.9052.5229,5577.711.78%16.30%20.90%6,301563
1,640.8035.1728,1528.430.00%31.40%31.50%4,159796
4,095.5064.6924,34711.570.07%32.80%37.50%3,722366
1,599.4045.3123,0155.330.00%13.80%16.80%2,973497
45.2520.6621,1832.070.33%10.60%13.40%7,9911,027
896.4064.9115,92011.240.11%25.70%21.60%7,005244
Median 7 companies1,599.4045.3124,3477.710.11%21.50%21.60%6,301563

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

57 Good

Data confidence 100/100

Category scores

Quality
81
Strong
Returns, margins, earnings quality 22% weight
Valuation
33
Poor
Cheap vs sector & own history 24% weight
Growth
82
Strong
Sales & profit trajectory 9% weight
Financial Health
51
Average
Solvency, leverage, coverage 9% weight
Momentum
62
Good
Trend strength, vol-adjusted 12% weight
Ownership
53
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 34.2% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 33.1%

Weaknesses

3
  • Stock is trading at 8.43 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company might be capitalizing the interest cost

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1153
OscillatorsNeutral252
Moving AveragesStrong Bearish901

Key readings

RSI (14)
44.15
Neutral
MACD (12,26,9)
−28.16
Bearish
SMA (50)
1,723.36
Bearish
SMA (200)
1,660.01
Bearish

As of

Analyst Rating

Based on 8 analysts
BUY88%

7 of 8 analysts rate Buy, 1 Hold, 0 Sell.

As of

BUY
7
88%
HOLD
1
13%
SELL
0
0%

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.

Revenue

Revenue growth by window
5Y+42.01%
3Y+45.78%
1Y+19.89%
TTM+43.31%

Net profit

Net profit growth by window
5Y+34.34%
3Y+33.27%
1Y+48.56%
TTM+30.28%

Operating cash flow

Operating cash flow growth by window
5Y+30.96%
3Y+32.77%
1Y+111.95%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
5Y−3.13 pp
3Y−4.08 pp
1Y+5.00 pp
TTM−0.13 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2020₹529 Cr
Mar 2021₹553 Cr
Mar 2022₹764 Cr
Mar 2023₹1,031 Cr
Mar 2024₹1,818 Cr
Mar 2025₹2,664 Cr
Mar 2026₹3,194 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2020₹137 Cr
Mar 2021₹165 Cr
Mar 2022₹233 Cr
Mar 2023₹305 Cr
Mar 2024₹370 Cr
Mar 2025₹486 Cr
Mar 2026₹722 Cr

Analyst Forecasts

Forecast For
Dec 26 consensus · EBITDA
₹453 Cr −2.5% vs Sep 26
Reported High Mean Low

AI Analysis — Bull vs Bear

Figures as of 19 Nov 2026
AI opinion · based on fundamentals
Risk high

Inventurus Knowledge Solutions Ltd trades at ₹1,606 as of 2026-11-19 with a market capitalisation of ₹27,555 crore and a trailing PE of 34.43x. The company has demonstrated strong revenue and profit compounding over five years (sales CAGR 42%, profit CAGR 34%) alongside robust return ratios (ROE 25.77%, ROCE 29.57%), but trades at a premium valuation of 8.25x book value and pays no dividend.

Bull Case 7
  • Compounded sales growth of 42% over the last 5 years and 46% over the last 3 years indicates a sustained, accelerating revenue trajectory
  • Compounded profit growth of 34% over 5 years and 30% over 3 years demonstrates strong earnings scalability alongside top-line expansion
  • TTM sales growth of 43% and TTM profit growth of 31% show that momentum remains intact in the most recent period
  • ROE of 25.77% and a 3-year average ROE of 33% reflect efficient capital allocation and high-quality earnings generation
  • ROCE of 29.57% suggests the business generates healthy returns on total capital employed, well above typical cost-of-capital benchmarks
  • Debt-to-equity ratio of just 0.27 indicates a conservatively financed balance sheet with limited leverage risk
  • The company is expected to deliver a good upcoming quarter, suggesting near-term earnings momentum may continue
Bear Case 6
  • At a PE of 34.43x, the stock is priced for continued high growth — any deceleration in the 30-40% earnings trajectory could trigger a de-rating
  • Zero dividend yield despite repeated profitability raises questions about capital return policy and shareholder alignment
  • The possibility that the company may be capitalising interest costs could mean reported profits overstate true operating earnings
  • 1-year stock CAGR of just 1% suggests the market has not rewarded the underlying earnings growth recently, pointing to possible valuation fatigue
  • Last-year ROE of 31% has declined from the 3-year average of 33% and 5-year average of 36%, signalling a gradual compression in return efficiency
  • A market cap of ₹27,555 crore paired with a TTM EPS of ₹46.65 implies the stock needs to sustain above-30% profit growth for several years to justify current pricing

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

1d ago

TL;DR: IKS delivered strong Q2FY27 results with 104% revenue growth and 18% profit growth, largely powered by the TruBridge acquisition. Corporate restructuring via the Turbo Health merger and acquisition signals ongoing integration of its US RCM business. No material headwinds are visible in recent news. The key forward question is whether the company can sustain growth and margin trajectory as acquisition-driven tailwinds normalize.

Positives 1
  • Q2 profit up 18% YoY Nov 5

    Consolidated net profit rose 18% YoY to ₹2,133.71 million in Q2FY27. Revenue surged 104% to ₹15,924.78 million, driven by the TruBridge acquisition.

Neutral 2
  • Turbo Health merger completed Nov 20

    Merger of Turbo Health Holdings with IKS Inc completed on November 20, 2026, with no cash consideration or share issuance. Consolidation aims to reduce compliance overheads for the newly acquired RCM entity.

  • Turbo Health acquired for $500K Nov 10

    US subsidiary acquired 100% of Turbo Health Holdings for $500,000. The target is a newly formed entity holding transferred client contracts.

Quarterly Results

₹ Cr
IKS quarterly results, ₹ crore
Particulars Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
567
620
640
643
657
724
740
781
815
858
894
1,592
Expenses
405
494
467
454
476
498
502
511
536
563
604
1,151
Operating Profit
162
126
173
189
181
226
238
270
279
295
290
442
OPM %
29%
20%
27%
29%
28%
31%
32%
35%
34%
34%
32%
28%
Other Income
6
15
4
5
27
3
3
4
6
5
6
23.38
Interest
26
32
26
22
21
21
18
16
23
13
10
102
Depreciation
19
27
28
28
28
28
28
30
32
34
34
89.79
PBT
124
81
122
144
160
180
195
229
229
253
251
273
Tax %
18%
21%
22%
21%
19%
18%
22%
21%
20%
19%
23%
22%
Net Profit
102
64
95
113
130
148
152
181
183
206
194
213
EPS (₹)
5.92
3.71
5.57
6.59
7.56
8.61
8.83
10.53
10.68
12.00
11.29
12.68
YoY Sales growth
—
—
—
—
16
17
16
22
24
18
21
104

Profit & Loss

₹ Cr
IKS profit and loss, annual, ₹ crore
Particulars Mar 2015 (S)Mar 2016 (S)Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
161
203
529
553
764
1,031
1,818
2,664
3,194
4,159
Expenses
139
149
367
348
466
639
1,297
1,893
2,110
2,854
Operating Profit
22
54
162
205
298
392
521
771
1,084
1,305
OPM %
14%
27%
31%
37%
39%
38%
29%
29%
34%
31%
Other Income
0
0
31
16
1
−2
40
39
17
40
Interest
8
8
7
8
7
6
61
89.77
70.25
148
Depreciation
5
10
40
30
23
25
59
113
124
190
PBT
8
36
145
183
269
359
442
606
905
1,006
Tax %
0%
0%
5%
9%
13%
15%
16%
20%
20%
—
Net Profit
8
36
137
165
233
305
370
486
722
796
EPS (₹)
0.48
2.11
8.01
9.64
13.58
17.79
21.59
28.33
42.03
46.65
Div. Payout %
0%
0%
0%
12%
393%
55%
0%
0%
0%
—
Sales growth
—
27
—
4
38
35
76
47
20
43

Balance Sheet

₹ Cr
IKS balance sheet, annual, ₹ crore
Particulars Mar 2015 (S)Mar 2016 (S)Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
8
8
8
8
17
17
17
17
17
17
Reserves
−40
−2
275
449
630
812
1,141
1,773
2,783
3,323
Borrowings
74
79
0
76
65
52
1,311
856
753
5,959
Other Liabilities
58
66
151
53
75
107
411
274
605
1,695
Total Liabilities
100
151
434
586
788
988
2,880
2,919
4,158
10,994
Fixed Assets
16
32
36
87
76
59
1,833
1,790
1,942
7,823
CWIP
14
26
0
0
0
0
3
13
6
0
Investments
4
4
1
14
16
32
195
114
377
157
Other Assets
66
88
397
485
695
898
849
1,003
1,832
3,013
Total Assets
100
151
434
586
788
988
2,880
2,919
4,158
10,994

Cash Flow

₹ Cr
IKS cash flow, annual, ₹ crore
Particulars Mar 2015 (S)Mar 2016 (S)Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
16
52
163
175
233
288
210
318
674
Investing
−21
−38
−79
−167
−82
−158
−1,137
241
−222
Financing
5
−2
−41
−37
−59
−152
780
−389
−412
Net Cash Flow
0
12
43
−28
92
−22
−147
170
39
Free Cash Flow
−5
13
152
168
222
280
177
276
614
CFO/EBITDA
75
109
118
100
93
93
58
56
80

Ratios

IKS financial ratios, annual
Particulars Mar 2015 (S)Mar 2016 (S)Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
130
101
51
49
46
57
73
73
65
Cash Conversion Cycle
130
101
51
49
46
57
73
73
65
Working Capital Days
−80
−38
20
41
15
21
−75
10
−31
ROCE %
—
70%
—
47%
47%
50%
30%
27%
32%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Inventurus Knowledge Solutions insights

67 extracted metrics across FY16–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 63.72%
  • Public 10.53%
  • Others 10.08%
  • FIIs 8.11%
  • DIIs 7.56%

No promoter shares pledged as of 14 Oct 2026

Change since Jun 2026

Documents

Frequently Asked Questions about Inventurus Knowledge Solutions

What does Inventurus Knowledge Solutions Ltd do?
Incorporated in 2006, Inventurus Knowledge Solutions Ltd provides healthcare solutions through its care enablement platform
Where is Inventurus Knowledge Solutions Ltd (IKS) listed?
Inventurus Knowledge Solutions Ltd trades as IKS on the NSE and under code 544309 on the BSE.
Which sector does Inventurus Knowledge Solutions Ltd belong to?
Inventurus Knowledge Solutions Ltd is classified under the Information Technology sector, in the IT - Services industry.
What is the market capitalisation of Inventurus Knowledge Solutions Ltd?
Inventurus Knowledge Solutions Ltd has a market capitalisation of ₹28,152 Cr as of 20 Nov 2026, which places it in the Smallcap band.
What is the PE ratio of Inventurus Knowledge Solutions Ltd?
Inventurus Knowledge Solutions Ltd trades at a PE ratio of 35.17 as of 20 Nov 2026, on earnings per share of ₹46.65, against a book value of ₹194.67 per share.
What is the 52-week high and low of Inventurus Knowledge Solutions Ltd?
Over the last 52 weeks Inventurus Knowledge Solutions Ltd has traded between ₹1,262 and ₹1,970 as of 20 Nov 2026.
What is the Return on Equity (ROE) of Inventurus Knowledge Solutions Ltd?
Inventurus Knowledge Solutions Ltd reported a return on equity of 31.40%. Its debt-to-equity ratio is 1.78.

Company Information

Incorporated in 2006, Inventurus Knowledge Solutions Ltd provides healthcare solutions through its care enablement platform

CEO Mr. Sachin K. Gupta
Employees 7,530
Listed 19 Dec 2024
Face Value ₹1
Shares Outstanding 17,15,73,159

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/IKS.md for Inventurus Knowledge Solutions Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More